摘要胰腺癌是一类高度致死性疾病,发病率高且预后极差,相关病死率接近其发生率.基于循证医学为依据的多学科综合诊断与治疗已日渐受到重视并成为胰腺癌诊断与治疗的主要模式.美国国立综合癌症网络(NCCN)每年发布的临床实践指南,已经得到广泛认可和遵循,2017 Ⅴ1版NCCN胰腺癌诊断与治疗指南已于近期发布.该指南在2016版指南的基础上进行了多处更新和修订.笔者团队就更新部分进行解读,以期为广大临床医师提供最新的胰腺癌诊断与治疗信息.

abstractsPancreatic adenocarcinoma is a highly lethal disease with a high morbidity and dismal prognosis.A multidisciplinary consultation based on evidence-based medicine has become the main modality for treatment of pancreatic adenocarcinoma.National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology has been widely recognized and implemented.Recently,the guidelines (version 1.2017) in oncology have been published by NCCN.This article will summarize and interpret the updates of the new version of the NCCN guideline for pancreatic adenocarcinoma.